Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2 as part of a minor revision to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-04T10:07:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2. This reflects a minor system/UI update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:43:12.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, and several help/navigation items were added while two formatting/version notes were removed or updated.
    Difference
    0.4%
    Check dated 2026-06-13T01:32:58.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    New site revision displayed as Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a platform update rather than changes to the study details or study content.
    Difference
    0.1%
    Check dated 2026-06-05T21:55:20.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-05-15T14:24:04.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov site revision label (from v3.5.2 to v3.5.3), reflecting a version change for the website interface rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.